Pantothenic Acid (Vitamin B5): Benefits, Dosage, and What the Research Says

Pantothenic acid - widely known as vitamin B5 - is a water-soluble B-vitamin found in nearly every food category. The name comes from the Greek word pantothen, meaning "from everywhere," which accurately describes how broadly distributed this nutrient is across both plant and animal sources. The body cannot synthesize pantothenic acid on its own and depends entirely on dietary intake or supplementation.¹

The U.S. Food and Nutrition Board classifies pantothenic acid under an Adequate Intake (AI) rather than a Recommended Dietary Allowance, because there is insufficient data to determine an Estimated Average Requirement. For adults aged 19 and older, the AI is 5 mg per day, rising to 6 mg during pregnancy and 7 mg during lactation.²

Pantothenic acid is sold in several supplemental forms:

• Calcium pantothenate - the most common oral salt form, present in most B-complex vitamins
• Pantethine - a more metabolically active, dimeric form that is the direct precursor to coenzyme A; studied specifically for lipid metabolism
• Dexpanthenol (panthenol) - the alcohol analog applied topically in skin and hair products; it converts to pantothenic acid in tissue

Rich food sources include beef liver (8.3 mg per 3-oz serving), sunflower seeds (2.4 mg per quarter cup), shiitake mushrooms (2.6 mg per half cup), fortified breakfast cereals, avocado, and chicken breast. Food processing - including cooking, freezing, canning, and grain refining - can destroy 20 to 80% of the pantothenic acid naturally present in foods.¹

True deficiency is rare in individuals eating a varied diet. When it does occur, usually alongside severe malnutrition, symptoms include fatigue, headache, irritability, numbness or burning in the hands and feet, and disturbed sleep.¹¹ A landmark human deficiency study found that urinary pantothenic acid excretion fell from 3.05 mg/day to 0.79 mg/day when subjects were placed on a deficient diet for 63 days, demonstrating measurable metabolic adaptation.¹¹

Pantothenic acid's defining biological role is as the rate-limiting precursor for the biosynthesis of coenzyme A (CoA) - one of the most broadly active cofactors in all of human biochemistry.² Inside cells, pantothenate kinase catalyzes the first and most tightly regulated step: phosphorylation of pantothenic acid. From there, a five-step biosynthetic cascade produces CoA, which participates in hundreds of enzymatic reactions.

The major metabolic roles of CoA include:

• Energy production - CoA is required at multiple points in the citric acid (Krebs) cycle, where acetyl-CoA derived from glucose, fatty acids, and amino acids is oxidized to generate ATP
• Fatty acid synthesis and oxidation - CoA activates fatty acids for both beta-oxidation (energy release) and anabolic lipid synthesis, including cell membrane phospholipids and steroid hormone backbones
• Steroid hormone production - the adrenal glands are particularly concentrated in CoA, and pantothenic acid supports steroidogenesis (synthesis of cortisol, aldosterone, and sex hormones)
• Neurotransmitter synthesis - CoA is required to synthesize acetylcholine, a key neurotransmitter involved in muscle function and cognition

Pantothenic acid also forms the acyl carrier protein (ACP) prosthetic group, which is an essential component of fatty acid synthase - the enzyme complex that assembles long-chain fatty acids for energy storage, membrane construction, and lipid signaling.²

Preclinical data suggest that adequate CoA availability influences sebaceous gland lipid output, adrenal steroid synthesis, and skin cell turnover - biochemical pathways that underlie the clinical applications described below. However, it is important to note that demonstrating a mechanistic role for CoA is not the same as proving that supplemental doses above the AI will produce a clinical benefit in healthy adults with adequate intake.

One of the most clinically investigated applications of supplemental pantothenic acid is in acne management. The biological rationale centers on CoA's role in regulating sebaceous gland lipid production: adequate CoA availability is theorized to help partition fatty acid metabolism away from sebum overproduction. At the cellular level, in vitro research shows that pantothenic acid depletion suppresses keratinocyte proliferation and reduces synthesis of keratinocyte growth factor and procollagen in fibroblasts - structural proteins critical to healthy skin turnover and repair.¹⁰

What the research shows

A 2014 randomized, double-blind, placebo-controlled trial enrolled 41 evaluable adults with mild to moderate facial acne. Participants received either a pantothenic acid-based dietary supplement providing 2.2 g/day or placebo for 12 weeks. At the primary endpoint, the treatment group demonstrated a statistically significant reduction in total facial lesion count compared to placebo (P = 0.0197), with inflammatory blemishes decreasing significantly as well. Quality-of-life scores improved meaningfully in the supplemented group, and the supplement was well tolerated throughout the trial.³

A 2023 systematic review published in JAMA Dermatology, which examined the safety and effectiveness of oral nutraceuticals for acne, identified this as the highest-quality trial available for pantothenic acid. The reviewers reported that the treatment group achieved a 68.2% greater reduction in total facial lesions versus the placebo group (P = 0.02), and that 42.9% of pantothenic acid recipients met Investigator's Global Assessment success criteria versus 14.3% in the placebo arm. The reviewers rated the overall quality of this evidence as fair and called for larger independent confirmatory trials.⁴

What this means for you: Research suggests that high-dose pantothenic acid supplementation may help support clearer skin in adults with mild to moderate acne. However, the evidence base consists of one small RCT, and the dose studied (2.2 g/day) substantially exceeds the standard daily AI. This should not be interpreted as a treatment for acne as a medical condition. Consult a dermatologist if acne is a significant concern.

Pantethine - a dimeric, metabolically active form of pantetheine that sits one biochemical step closer to CoA than standard pantothenic acid - has been investigated in controlled trials for its effects on blood lipid profiles. This research is distinct from studies of calcium pantothenate; lipid effects appear to be specific to the pantethine form and are not confirmed for standard B5 supplements.

What the research shows

A 2011 triple-blind, placebo-controlled trial enrolled 120 North American adults with low to moderate cardiovascular risk who were maintained on a therapeutic lifestyle change diet throughout the study. Participants received either pantethine (600 mg/day during weeks 1-8, increasing to 900 mg/day during weeks 9-16) or matched placebo. Compared to placebo, the pantethine group showed statistically significant reductions in total cholesterol (3%), LDL cholesterol (4%), and apolipoprotein B (5%) by the end of the 16-week intervention.⁵ The authors noted that each 1 mg/dL reduction in LDL-C is associated with approximately 1% reduction in future cardiovascular event risk.

A 2014 triple-blind RCT in 32 participants with low to moderate cardiovascular risk replicated these findings at a more pronounced magnitude. Over 16 weeks, the pantethine group showed an 11% reduction in LDL cholesterol from baseline, while the placebo group's LDL increased by 3% over the same period. Total cholesterol and non-HDL cholesterol reductions were statistically significant at weeks 8 and 16 (P values ranging from 0.006 to 0.042).⁶

Important context: Both trials are small (n = 32 and n = 120), and the absolute reductions in LDL were modest - in the range of 4 to 11% from baseline. Pantethine is not a replacement for prescribed lipid-lowering medications, and individuals with dyslipidemia should work with their physician before starting or adjusting any supplement. These findings do not apply to standard calcium pantothenate supplements.

Dexpanthenol, the topical alcohol form of pantothenic acid, is one of the most commonly used active ingredients in post-procedure wound care and cosmetic moisturizers. The CoA turnover rate in damaged or inflamed skin is particularly high, creating a locally elevated demand for pantothenate precursors - a rationale that supports topical rather than oral delivery for skin repair applications.

What the research shows

A 2020 narrative review synthesized prospective clinical data alongside gene-expression studies. The authors concluded that topically applied dexpanthenol promotes superficial and post-procedure wound healing by upregulating genes involved in the repair cascade - including IL-6, IL-1 beta, CXCL1, and CCL18 - while accelerating re-epithelialization and restoring skin barrier function following skin injury.⁸

A 2002 review of the use of topical dexpanthenol in skin disorders reported consistent evidence across multiple clinical settings: dexpanthenol improves stratum corneum hydration, reduces transepidermal water loss, stimulates fibroblast proliferation, and accelerates re-epithelialization. Beneficial effects were observed in patients with burns, scar tissue, transplanted skin, and various inflammatory dermatoses. Topical dexpanthenol preparations were generally well tolerated, with minimal risk of irritation or sensitization.⁹

One double-blind, prospective, randomized trial examined oral pantothenic acid (0.2 g/day) combined with ascorbic acid (1.0 g/day) in 49 patients undergoing surgery for tattoo removal over 21 days. While supplementation altered trace element composition in wound tissue, the authors concluded that "no major improvement of the wound healing process could be documented" at the oral doses tested.⁷

Bottom line: Clinical and mechanistic evidence supports topical dexpanthenol for wound healing and skin barrier repair. Evidence for oral pantothenic acid supplementation on post-surgical wound healing is weaker, and the one available RCT found no significant benefit at nutritional doses.